Navigation Links
Fruit2O(R) Introduces New 'Essentials' Line
Date:6/4/2009

nutrients combined with the refreshment of water to help them live a healthy, happy lifestyle. Every Fruit2O product still contains zero calories, zero sugar and zero or few carbohydrates per serving, just like the original Fruit2O flavored water. The Fruit2O brand is owned by the Sunny Delight Beverage Company based in Cincinnati, Ohio. To learn more about Fruit2O and its newest offerings, visit WWW.FRUIT2O.COM.


'/>"/>
SOURCE Fruit2O
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Delta Dental of Illinois Introduces Smile Smart For Your Health
2. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
3. Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
4. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
5. GladRags Introduces the Moon Cup - An Environmentally-Sound and Safe Alternative to Disposable Feminine Hygiene Products!
6. Triveris Introduces Personal Health Record with Built-in Health Advisor
7. Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region
8. Mecklenburg EMS Introduces Most-Advanced Situational Training in America for Emergency Medical Personnel
9. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
10. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
11. ThermoTx Introduces New Mobile Stimulation (TENS) Product Line for On the Go Therapy and Pain Relief

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)... that can occur in children with autism and relate...that includes medication combined with a structure...University researchers and their colleagues. , ...al of the American Academy of Child and Adolescent...nal Institute of Mental Health (NIMH) Research Uni...
(Date:11/25/2009)...ace.com, the premier resource for life science car...f the BioForest™ Hotbed Campaign this mornin...) November 25, 2009 -- BioSpace.com, the premier r...unveiled the third edition of the BioForest™...nal campaign is a promotional effort highlighting ...
(Date:11/25/2009)...onEverMadeinSupportofFeedingAmerica,sSNAPOutreachE.../--FeedingAmerica,thenation,slargesthunger-reliefo...eBankofAmericaCharitableFoundationtosupportFeeding...eSupplementalNutritionAssistanceProgram(SNAP),form...elpFeedingAmericafoodbanksimproveaccessandprovidep...
(Date:11/25/2009)...ociety of,Hematology (ASH) is pleased to recogniz...est scoring abstracts in the categories of undergr..., resident physician, and post-doctoral,fellow. M...annual meeting,travel reimbursement. , The 2009...tudent , Kimberly Fan , Donor Dendritic Cells ...
(Date:11/25/2009)...y lead to new drugs for people, researchers say ,... Sphingadienes, natural lipid molecules found in s...r colon cancer, California researchers have found.... authors pointed out that they could help explain ...cancer. , In the study, Dr. Julie Saba, senior ...
Breaking Medicine News(10 mins):Health News:Parent training key to improved treatment of behavior problems in children with autism 2Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2Health News:Bank of America Charitable Foundation Presents $1 Million Contribution to Feeding America in an Effort to Help Connect Low-Income Americans With Federal Nutrition Programs 2Health News:Bank of America Charitable Foundation Presents $1 Million Contribution to Feeding America in an Effort to Help Connect Low-Income Americans With Federal Nutrition Programs 3Health News:ASH announces 2009 Merit Award winners 2Health News:Natural Soy Component May Help Treat Colon Cancer 2
...riple-S,Management Corporation (NYSE: GTS ) today... Chief Executive Officer, and Juan-Jose Roman,Fina...ll present to,investors and financial analysts at ... the Internet and will remain,archived for 90 days...
...dco Health,Solutions, Inc. (NYSE: MHS ) plans to ...ancial results in a press release before the marke... release, management will hold a conference call t...5383 from inside the U.S., or (706) 679-3440 from,...
...: HRAL) -,HearAtLast Holdings, Inc. is proud to an...al-Mart Canada (NYSE: WMT ) to open its 18th hear...-Mart Store #5778 located at 135,First Commerce Dr...s co-located in Wal-Mart Stores, Wal-Mart,Supercen...
...nto Stock Exchange Symbol: AKL, MONTREAL, Feb. 4 ...AKL"), a drug development company focused on devel...s, today announced that it has received notice,fro...ntly evaluating several alternative remedies and a...
...study published in the February 2008 issue of Pedi...nfluenza have had a recent, previous hospitalizati...portunity to receive a hospital-based influenza va...ional hospitalizations and complications from infl...
...tic options to reduce severity of disease, ...AN ANTONIO, Feb. 3 Atopic dermatitis, one of the ...ous inflammatory skin,diseases, is a chronic disea...ins in the first year of life. Although the,diseas...
Other Medicine News:Health News:Medco Announces Date for Fourth-Quarter and Full-Year 2007 Financial Results 2Health News:HearAtLast Expands Chain to 18 Locations Opening New Clinic in Aurora, Ontario Wal-Mart Store # 5778 2Health News:HearAtLast Expands Chain to 18 Locations Opening New Clinic in Aurora, Ontario Wal-Mart Store # 5778 3Health News:HearAtLast Expands Chain to 18 Locations Opening New Clinic in Aurora, Ontario Wal-Mart Store # 5778 4Health News:Akela Pharma receives letter from the FDA regarding its pre-clinical toxicology studies for Fentanyl TAIFUN(R) 2Health News:New hospital standards needed for pediatric flu vaccines 2Health News:New hospital standards needed for pediatric flu vaccines 3Health News:American Academy of Dermatology Research Confirms Genetic Skin Barrier Defect Linked to Eczema 2Health News:American Academy of Dermatology Research Confirms Genetic Skin Barrier Defect Linked to Eczema 3Health News:American Academy of Dermatology Research Confirms Genetic Skin Barrier Defect Linked to Eczema 4
(Date:11/24/2009)...rics,Inc.,aprivately-helddeveloperandmarketerofthe...iagnosticsystemformeasuringanindividual,sresponset...irin),announcedtodaythatTimothyI.Still,Presidentan...ialOfficerofAccumetrics,willbepresentingacorporate...rencebeingheldinNewYorkCityonDecember1-2,2009atThe...
(Date:11/24/2009)...rmaceuticalInstitute,aleadingproviderofspecialized...ustry,todayannouncedthelaunchofanewe-coursetitled,...-courseisthenewestadditiontothecompany,s ManagedMa...-coursesdesignedtofillthecriticalneedforbasicandad...onals. ,, Thenewthreemodule HospitalMarketplace...
(Date:11/24/2009)...finiteMind ,aSaltLakeCitybasedsoftwarecompany,anno...,thesoftwareprogramistobeusedinconjunctionwithexis...ucedattheCOVDconferencethisOctoberinColorado.Curre...he eyeQ programaddssignificantvaluetohispractice,S...ientstoembedpracticesfromtheofficesettingtothecomf...
Breaking Medicine Technology:Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Pharmaceutical Institute Launches New Training Resource Focused on the Hospital Marketplace 2Infinite Mind Announces the Launch of a New Online Vision Therapy Program eyeQ 2Partnership for Prescription Assistance Prepared to Help South Carolina Workers Hurt by Recession 57800 1Partnership for Prescription Assistance Prepared to Help South Carolina Workers Hurt by Recession 57800 2Partnership for Prescription Assistance Prepared to Help South Carolina Workers Hurt by Recession 57800 3Partnership for Prescription Assistance Prepared to Help South Carolina Workers Hurt by Recession 57800 4Adnan H Tahir M D Named Chief Medical Officer of Sisters of Charity Health System 57796 1Adnan H Tahir M D Named Chief Medical Officer of Sisters of Charity Health System 57796 2Adnan H Tahir M D Named Chief Medical Officer of Sisters of Charity Health System 57796 3Abbotts XIENCE V 28R 29 Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long Term Safety Results in SPIRIT III Trial 5024 1Abbotts XIENCE V 28R 29 Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long Term Safety Results in SPIRIT III Trial 5024 2Abbotts XIENCE V 28R 29 Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long Term Safety Results in SPIRIT III Trial 5024 3Abbotts XIENCE V 28R 29 Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long Term Safety Results in SPIRIT III Trial 5024 4Abbotts XIENCE V 28R 29 Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long Term Safety Results in SPIRIT III Trial 5024 5Abbotts XIENCE V 28R 29 Continues to Outperform TAXUS With Sustained Clinical Advantages and Impressive Long Term Safety Results in SPIRIT III Trial 5024 6
...enapine in the treatment of schiz...8 Schering-Plough Corporation,(NYSE: SGP ) today...trials,from the Olympia program was presented at t...c Association in Washington, D.C., May 3-8. Data f... disorder and schizophrenia,were presented in two ...
...the American Pain Society ...ed with lacosamide,demonstrated sustained pain rel...to placebo-treated patients, according to data pre...Pain Society (APS) in Tampa, Fla., "This is the f...athic,pain treatment providing evidence of long-te...
Other Medicine Technology:Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 2Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 3Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 4Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 5Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 6Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting 7New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 2New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 3New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 4
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: